If you don't use it, you're going to lose it—the old chestnut is supported by a new VA Medical Center study showing that fit elderly patients with hypertension had a lower risk of death than those with low levels of cardiorespiratory fitness.
Earlier this week, the Institute of Medicine stirred up controversy when it stated the data are insufficient to recommend lowering sodium levels beyond 2300 mg per day. The AHA came out against the IOM report, but hypertension experts heartwire spoke with say the recommendations are right on the money.
Citing a lack of evidence linking lower sodium targets to a reduction in hard events, the IOM concludes that while Americans are consuming more sodium than required for health, the low limits set for certain high-risk groups are not supported by current evidence. The AHA respectfully disagrees.
A new study published today showed that while the sodium content of processed foods declined from 2005 to 2011, the overall reduction was just 3.5%. Restaurants, on the other hand, fared even worse, with researchers reporting that sodium levels actually increased by 2.6% over the same six-year period.
Professional societies have released an update to the "core competence" required of physicians wanting to perform percutaneous coronary interventions. In it, average annual volumes are lower, while patient-centered care, procedure appropriateness, and awareness of personal stats have moved to the forefront.
UPDATED // Guidelines recommend that patients at high risk for thromboembolic events be bridged with heparin therapy, but few randomized trials have compared this strategy with simply maintaining patients on warfarin for their procedures.
N-3 fatty-acid supplementation had no effect on the study's primary end point in this group of patients with multiple cardiovascular risk factors or atherosclerotic disease, but no previous MI. Researchers also saw no effects on the rate of death from coronary causes or sudden death from cardiac causes or major ventricular arrhythmias.
Almost 35 000 patients in 11 European countries underwent a transcatheter aortic-valve replacement in the first five years following CE Mark approval of the Edwards Sapien and Medtronic CoreValve, according to a newly published tally.
The AHA is reminding physicians in clinical practice that the domains of patient-reported health status, including symptom burden, functional status, and health-related quality of life, remain underused despite their usefulness in informing clinical decision making and understanding disease burden.
One of the Lancet papers reviews the successes, failures, and ongoing challenges in beating back the "global tobacco epidemic," including a report from FDA scientists touting the impact of the 2009 Tobacco Control Act in the US.
It used to be easier deciding which oral anticoagulant to use in patients with nonvalvular atrial fibrillation. With all the choices now available, a new document sorts out their differences and can guide their use in various clinical settings.
A nationwide cohort study in Denmark helps to soften the message from a 2012 study linking the antibiotic to an increased risk of cardiovascular death in the elderly, likely from ventricular arrhythmias, according to researchers; the hazard doesn't seem to apply to younger people in the general population.
Experts who commented on the study, conducted by Canadian naturopathic physicians, said cardiologists should keep their minds open to whatever strategies might help patients do better at reducing their risk of future events.
It's never been clear whether the telltale metabolic signs at hospitalization tell the same prognostic story as in the outpatient setting. Certainly it wasn't known whether they had their own story to tell.
The ESC says that catheter-based renal denervation can be considered a therapeutic option in patients with drug-resistant hypertension who cannot get to goal with a combination of lifestyle and pharmacologic therapy.